Additional findings_Adult
Gene: CDC73
CDC73-related conditions are considered as a spectrum that includes three phenotypes: HPRT2; hyperparathyroidism 1 (HPRT1; also known as familial isolated hyperparathyroidism or FIHP) and parathyroid carcinoma (PC).
To establish the extent of disease and needs in an individual initially diagnosed with HRPT2, the following are recommended:
•Evaluation for jaw tumors with panoramic jaw x-ray
•Evaluation for renal lesions with ultrasound examination
•Evaluation of standard skeletal and renal end organ damage of pHPT
•Evaluation for uterine tumors with pelvic ultrasound examination, CT, or MRI (starting at reproductive age).
Individuals newly diagnosed with any CDC73-related condition who have evidence of pHPT should be evaluated using a 24-hour urine calcium-to-creatinine clearance ratio.
Hypercalcemic individuals (including asymptomatic) with pathogenic variants in CDC73 should be evaluated for pHPT (concomitant calcium and intact [i]PTH levels) and should be managed in consultation with an endocrinologist, with consideration given to referral to a high-volume parathyroid surgeon.
Sources: Expert listCreated: 11 Apr 2025, 8:49 a.m.
Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Phenotypes
Hyperparathyroidism-jaw tumour syndrome, MIM# 145001; Hyperparathyroidism, familial primary, MIM# 145000
Gene: cdc73 has been classified as Green List (High Evidence).
Gene: cdc73 has been classified as Green List (High Evidence).
gene: CDC73 was added gene: CDC73 was added to Additional findings_Adult. Sources: Expert list Mode of inheritance for gene: CDC73 was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted Phenotypes for gene: CDC73 were set to Hyperparathyroidism-jaw tumour syndrome, MIM# 145001; Hyperparathyroidism, familial primary, MIM# 145000 Review for gene: CDC73 was set to GREEN